New Drug May Help Victims Of Traumatic Brain Injuries
The University of Cincinnati is spearheading a national clinical trial to identify whether a medicine called Tranexamic Acid (TXA) can improve the conditions of individuals with severe and life-threatening Traumatic Brain Injuries (TB). Researchers are hopeful that the new drug, which is currently used to stabilize bleeding in victims with conditions ranging from aneurysms and liver transplantation, will improve the lives of those with TBI. The study is designed to test whether TXA, if given to TBI victims immediately after an injury, can improve patients mental recovery. University of Cincinnati’s sprawling hospital and trauma center make them a perfect venue to test whether TBI trauma victims with quick exposure to TXA recover more fully or more quickly than their counterparts